Skip to main content

Advertisement

SpringerLink
Log in

A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Franchini M, Lippi G (2011) Acquired factor V inhibitors: a systematic review. J Thromb Thrombolysis 31:449–457

    Article  CAS  Google Scholar 

  2. Knobl P, Lechner K (1998) Acquired factor V inhibitors. Baillieres Clin Haematol 11:305–318

    Article  CAS  Google Scholar 

  3. Giannouli S, Voulgarelis M, Zintzaras E, Tzioufas AG, Moutsopoulos HM (2004) Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology (Oxford) 43:626–632

    Article  CAS  Google Scholar 

  4. Milojkovic D, Patel R, Ford E, Arya R, Mufti G (2007) Acquired factor V inhibitor after haematopoietic stem cell transplantation. Thromb Haemost 98:685–687

    Article  CAS  Google Scholar 

  5. Chediak J, Ashenhurst JB, Garlick I, Desser RK (1980) Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions. Blood 56:835–841

    CAS  Google Scholar 

  6. Tracy PB, Eide LL, Bowie EJ, Mann KG (1982) Radioimmunoassay of factor V in human plasma and platelets. Blood 60:59–63

    CAS  Google Scholar 

  7. Ang AL, Kuperan P, Ng CH, Ng HJ (2009) Acquired factor V inhibitor. A problem-based systemic review. Thromb Haematol 101:852–859

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Yokohama Municipal Citizen’s Hospital, 56 Okazawa-cho, Hodogaya-ku, Yokohama, 240-8555, Japan

    Yuriko Fujita, Tomonori Nakazato, Chisako Ito, Kyoko Masuda, Yuki Osada & Yoshinobu Aisa

  2. Division of Hematology, Keio University School of Medicine, Tokyo, Japan

    Takehiko Mori

Authors
  1. Yuriko Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tomonori Nakazato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chisako Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kyoko Masuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuki Osada
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshinobu Aisa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takehiko Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomonori Nakazato.

Ethics declarations

Informed consent

Written informed consent was obtained from the patient for publication.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fujita, Y., Nakazato, T., Ito, C. et al. A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment. Ann Hematol 97, 2009–2010 (2018). https://doi.org/10.1007/s00277-018-3348-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-018-3348-z

Keywords

Search

Navigation